rs2066520

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_014140.4(SMARCAL1):​c.1271A>T​(p.Asp424Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00301 in 1,614,204 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0021 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0031 ( 12 hom. )

Consequence

SMARCAL1
NM_014140.4 missense

Scores

3
12
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:9

Conservation

PhyloP100: 9.18
Variant links:
Genes affected
SMARCAL1 (HGNC:11102): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1) The protein encoded by this gene is a member of the SWI/SNF family of proteins. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein shows sequence similarity to the E. coli RNA polymerase-binding protein HepA. Mutations in this gene are a cause of Schimke immunoosseous dysplasia (SIOD), an autosomal recessive disorder with the diagnostic features of spondyloepiphyseal dysplasia, renal dysfunction, and T-cell immunodeficiency. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014533311).
BP6
Variant 2-216428719-A-T is Benign according to our data. Variant chr2-216428719-A-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 283080.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=2, Benign=1}. Variant chr2-216428719-A-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00212 (323/152334) while in subpopulation NFE AF= 0.00353 (240/68028). AF 95% confidence interval is 0.00316. There are 0 homozygotes in gnomad4. There are 144 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SMARCAL1NM_014140.4 linkuse as main transcriptc.1271A>T p.Asp424Val missense_variant 7/18 ENST00000357276.9 NP_054859.2 Q9NZC9
SMARCAL1NM_001127207.2 linkuse as main transcriptc.1271A>T p.Asp424Val missense_variant 7/18 NP_001120679.1 Q9NZC9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SMARCAL1ENST00000357276.9 linkuse as main transcriptc.1271A>T p.Asp424Val missense_variant 7/182 NM_014140.4 ENSP00000349823.4 Q9NZC9

Frequencies

GnomAD3 genomes
AF:
0.00212
AC:
323
AN:
152216
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.00177
Gnomad ASJ
AF:
0.00230
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00353
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.00229
AC:
577
AN:
251494
Hom.:
3
AF XY:
0.00232
AC XY:
315
AN XY:
135920
show subpopulations
Gnomad AFR exome
AF:
0.000615
Gnomad AMR exome
AF:
0.00119
Gnomad ASJ exome
AF:
0.00337
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00147
Gnomad FIN exome
AF:
0.00102
Gnomad NFE exome
AF:
0.00351
Gnomad OTH exome
AF:
0.00423
GnomAD4 exome
AF:
0.00310
AC:
4536
AN:
1461870
Hom.:
12
Cov.:
32
AF XY:
0.00311
AC XY:
2260
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.000299
Gnomad4 AMR exome
AF:
0.00121
Gnomad4 ASJ exome
AF:
0.00302
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00145
Gnomad4 FIN exome
AF:
0.00116
Gnomad4 NFE exome
AF:
0.00363
Gnomad4 OTH exome
AF:
0.00270
GnomAD4 genome
AF:
0.00212
AC:
323
AN:
152334
Hom.:
0
Cov.:
33
AF XY:
0.00193
AC XY:
144
AN XY:
74504
show subpopulations
Gnomad4 AFR
AF:
0.000505
Gnomad4 AMR
AF:
0.00176
Gnomad4 ASJ
AF:
0.00230
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000622
Gnomad4 FIN
AF:
0.000565
Gnomad4 NFE
AF:
0.00353
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.00322
Hom.:
0
Bravo
AF:
0.00238
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00244
AC:
21
ExAC
AF:
0.00232
AC:
282
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00311
EpiControl
AF:
0.00385

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:4
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2022SMARCAL1: BS1 -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJul 19, 2024In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Schimke immuno-osseous dysplasia Uncertain:1Benign:3
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Benign, no assertion criteria providedclinical testingNatera, Inc.Dec 31, 2019- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingCenter for Genomics, Ann and Robert H. Lurie Children's Hospital of ChicagoMar 30, 2021SMARCAL1 NM_014140.3 exon 7 p.Asp424Val (c.1271A>T):This variant has not been reported in the literature but is present in 0.3% (453/129196) of European alleles, including 2 homozygotes in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/2-217293442-A-T?dataset=gnomad_r2_1). This variant is present in ClinVar, with several labs classifying this variant as Likely Benign or Benign (Variation ID:283080). Evolutionary conservation suggests that this variant may impact the protein; computational predictive tools for this variant are unclear. In summary, data on this variant suggests that this variant does not cause disease, but requires further evidence. Therefore, the clinical significance of this variant is uncertain. -
Kidney disorder Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenDec 12, 2016- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Sep 21, 2015- -
SMARCAL1-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJun 05, 2020This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Pathogenic
0.44
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.20
T;T;T;T
Eigen
Uncertain
0.31
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
.;D;D;D
M_CAP
Uncertain
0.096
D
MetaRNN
Benign
0.015
T;T;T;T
MetaSVM
Uncertain
0.31
D
MutationAssessor
Uncertain
2.6
M;M;.;.
PrimateAI
Uncertain
0.52
T
PROVEAN
Pathogenic
-6.5
D;D;D;D
REVEL
Uncertain
0.56
Sift
Uncertain
0.0010
D;D;D;T
Sift4G
Uncertain
0.0020
D;D;D;D
Polyphen
0.040
B;B;.;.
Vest4
0.67
MVP
0.97
MPC
0.98
ClinPred
0.077
T
GERP RS
6.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.61
gMVP
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2066520; hg19: chr2-217293442; COSMIC: COSV99050872; COSMIC: COSV99050872; API